Stock Market News

Citi initiates coverage on 5 new biotech stocks

2024.11.14 09:44

Citi initiates coverage on 5 new biotech stocks

Investing.com — Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:), Biogen (NASDAQ:), Gilead (NASDAQ:), Regeneron (NASDAQ:), and Vertex (NASDAQ:).

The firm initiated coverage on Gilead and Vertex with Buy ratings, citing solid growth drivers, while Amgen, Biogen, and Regeneron received Neutral ratings due to certain market challenges and pipeline uncertainties.

For Amgen, Citi analysts underscore the potential of its obesity and diabetes drug, MariTide, though the firm remains cautious due to competitive pressures in the GLP-1 market.

They believe the company’s growth outlook “hinges on MariTide clinical success and to a lesser degree, the trajectory for a number of newer products,” such as Tepezza, Uplizna, Krystexxa, and Imdelltra.

Vertex also earned a Buy rating at Citi, primarily due to its leadership in cystic fibrosis and the potential from new therapies, including the vanzacaftor triple combination for CF and suzetrigine for acute pain.

“Given consistent growth in CF, with multiple PDUFA dates in early 2025 and a clear path to broader diversification, we are very positive on the growth story for Vertex,” analysts led by Geoff Meacham wrote.

Meanwhile, Biogen’s Neutral rating reflects an acknowledgment of erosion in its core franchises, although near-term growth could stem from new launches in Alzheimer’s (Leqembi) and through potential mergers & acquisitions.

But despite pipeline developments, Citi cautions that “Biogen’s pipeline still looks to have higher clinical risk overall versus Big Biotech peers,” with key readouts in Alzheimer’s, multiple sclerosis, and Parkinson’s expected over the next two years.

Gilead, receiving a Buy rating, is viewed favorably for its robust HIV business and future potential from its HIV prevention drug lenacapavir, anticipated for launch in 2025.

“Led by Biktarvy, Gilead’s core HIV business continues to show strong growth with recent upside sales driven by higher demand not pricing,” analysts said.

“We see Biktarvy as the pillar of the HIV business as it continues to dominate share (>49%) in the HIV treatment market,” they added and cited potential upside from lenacapavir, Trodelvy in oncology, and growth within cell therapies.

For Regeneron, Citi’s Neutral stance hinges on expected declines in its Eylea franchise due to biosimilar competition. Still, the report states that “the long-term potential holds promise for growth,” supported by Regeneron’s Dupixent and Libtayo franchises.

Phase 3 results in melanoma and non-small cell lung cancer could be important catalysts for Regeneron, with data expected by late 2024 and 2025.



Source link

Related Articles

Back to top button
bitcoin
Bitcoin (BTC) $ 87,810.53 1.49%
ethereum
Ethereum (ETH) $ 3,103.41 1.19%
tether
Tether (USDT) $ 1.00 0.73%
solana
Solana (SOL) $ 213.67 1.69%
bnb
BNB (BNB) $ 634.22 4.00%
dogecoin
Dogecoin (DOGE) $ 0.387002 0.69%
xrp
XRP (XRP) $ 0.787204 15.95%
usd-coin
USDC (USDC) $ 1.00 0.61%
staked-ether
Lido Staked Ether (STETH) $ 3,102.40 1.06%
cardano
Cardano (ADA) $ 0.559581 1.59%
tron
TRON (TRX) $ 0.177552 1.45%
shiba-inu
Shiba Inu (SHIB) $ 0.000025 0.74%
the-open-network
Toncoin (TON) $ 5.36 3.71%
wrapped-steth
Wrapped stETH (WSTETH) $ 3,689.09 1.47%
avalanche-2
Avalanche (AVAX) $ 31.94 1.22%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 87,901.55 1.30%
sui
Sui (SUI) $ 3.35 4.12%
pepe
Pepe (PEPE) $ 0.000022 17.90%
weth
WETH (WETH) $ 3,104.85 1.41%
bitcoin-cash
Bitcoin Cash (BCH) $ 419.86 3.38%
chainlink
Chainlink (LINK) $ 13.15 0.89%
polkadot
Polkadot (DOT) $ 4.86 3.02%
leo-token
LEO Token (LEO) $ 7.43 2.17%
near
NEAR Protocol (NEAR) $ 5.41 6.85%
litecoin
Litecoin (LTC) $ 81.74 10.61%
aptos
Aptos (APT) $ 11.41 1.29%
wrapped-eeth
Wrapped eETH (WEETH) $ 3,271.10 1.10%
usds
USDS (USDS) $ 0.997105 0.12%
uniswap
Uniswap (UNI) $ 8.36 1.26%
crypto-com-chain
Cronos (CRO) $ 0.154849 6.60%
dogwifcoin
dogwifhat (WIF) $ 3.99 0.73%
stellar
Stellar (XLM) $ 0.133162 9.17%
internet-computer
Internet Computer (ICP) $ 8.11 2.97%
bittensor
Bittensor (TAO) $ 498.71 5.20%
kaspa
Kaspa (KAS) $ 0.147007 16.46%
ethereum-classic
Ethereum Classic (ETC) $ 22.07 1.96%
fetch-ai
Artificial Superintelligence Alliance (FET) $ 1.26 1.45%
dai
Dai (DAI) $ 0.999659 0.17%
whitebit
WhiteBIT Coin (WBT) $ 22.14 0.19%
ethena-usde
Ethena USDe (USDE) $ 1.00 0.16%
polygon-ecosystem-token
POL (ex-MATIC) (POL) $ 0.362375 2.14%
blockstack
Stacks (STX) $ 1.83 2.75%
render-token
Render (RENDER) $ 6.83 0.66%
monero
Monero (XMR) $ 145.77 1.84%
okb
OKB (OKB) $ 43.62 1.52%
bonk
Bonk (BONK) $ 0.000037 3.84%
hedera-hashgraph
Hedera (HBAR) $ 0.065015 12.68%
aave
Aave (AAVE) $ 160.97 5.11%
mantle
Mantle (MNT) $ 0.711958 2.11%
first-digital-usd
First Digital USD (FDUSD) $ 1.00 1.03%